Skip to search form
Skip to main content
>
Semantic Scholar
Semantic Scholar's Logo
Search
Sign In
Create Free Account
You are currently offline. Some features of the site may not work correctly.
(124)I-cMAb U36
Known as:
124I-cMAb U36
National Institutes of Health
Create Alert
Related topics
Related topics
2 relations
Broader (2)
Monoclonal Antibodies
cMAb U36
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Radiation Dosimetry of 89Zr-Labeled Chimeric Monoclonal Antibody U36 as Used for Immuno-PET in Head and Neck Cancer Patients
Pontus K. E. Börjesson
,
Yvonne W. S. Jauw
,
+5 authors
R. Boellaard
Journal of Nuclear Medicine
2009
Corpus ID: 5497604
Immuno-PET is an appealing concept in the detection of tumors and planning of antibody-based therapy. For this purpose, the long…
Expand
2008
2008
Targeting CD44v6 Expressed in Head and Neck Squamous Cell Carcinoma: Preclinical Characterization of an 111In-Labeled Monoclonal Antibody
K. Sandström
,
M. Nestor
,
T. Ekberg
,
M. Engström
,
M. Anniko
,
H. Lundqvist
Tumor Biology
2008
Corpus ID: 23158310
In patients with head and neck squamous cell carcinoma (HNSCC) radioimmunodiagnosis could offer a more specific and sensitive…
Expand
2005
2005
In vitro evaluation of the astatinated chimeric monoclonal antibody U36, a potential candidate for treatment of head and neck squamous cell carcinoma
M. Nestor
,
M. Persson
,
+4 authors
V. Tolmachev
European Journal of Nuclear Medicine and…
2005
Corpus ID: 21594698
PurposeThe purpose of this study was to analyse the properties of the astatinated chimeric MAb (cMAb) U36 as a conjugate to…
Expand
2005
2005
Construction and characterization of the chimeric monoclonal antibody E48 for therapy of head and neck cancer
R. Brakenhoff
,
Frank B. van Gog
,
J. Looney
,
Marijke van Walsum
,
G. Snow
,
G. A. Dongen
Cancer Immunology, Immunotherapy
2005
Corpus ID: 1076853
Data from an ongoing clinical radioimmunoscintigraphy trial indicate that99mTc-labeled monoclonal antibody (mAb) E48 is highly…
Expand
Highly Cited
2004
Highly Cited
2004
High-quality 124I-labelled monoclonal antibodies for use as PET scouting agents prior to 131I-radioimmunotherapy
I. Verel
,
G. W. Visser
,
M. Vosjan
,
R. Finn
,
R. Boellaard
,
G. A. Dongen
European Journal of Nuclear Medicine and…
2004
Corpus ID: 22039987
PurposeMonoclonal antibodies (MAbs) labelled with 124I are an attractive option for quantitative imaging with positron emission…
Expand
2003
2003
Biodistribution of the chimeric monoclonal antibody U36 radioiodinated with a closo-dodecaborate-containing linker. Comparison with other radioiodination methods.
M. Nestor
,
M. Persson
,
+4 authors
K. Kairemo
Bioconjugate chemistry
2003
Corpus ID: 23044781
We have evaluated the applicability of the [(4-isothiocyanatobenzylammonio)undecahydro-closo-dodecaborate (1-)] (DABI) linker…
Expand
2002
2002
Reinfusion of unprocessed, granulocyte colony-stimulating factor-stimulated whole blood allows dose escalation of 186Relabeled chimeric monoclonal antibody U36 radioimmunotherapy in a phase I dose…
D. Colnot
,
G. Ossenkoppele
,
+6 authors
G. V. van Dongen
Clinical cancer research : an official journal of…
2002
Corpus ID: 8179819
PURPOSE In an earlier Phase I radioimmunotherapy (RIT) study with rhenium-186-labeled chimeric monoclonal antibody (cMAb) U36 in…
Expand
Highly Cited
2000
Highly Cited
2000
Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck.
D. Colnot
,
J. Quak
,
+6 authors
G. V. van Dongen
Journal of nuclear medicine : official…
2000
Corpus ID: 6099418
UNLABELLED A phase I therapy study was conducted to determine the safety, maximum tolerated dose (MTD), pharmacokinetics…
Expand
Highly Cited
2000
Highly Cited
2000
Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy
M. B. Vrouenraets
,
G. W. Visser
,
+6 authors
G. V. van Dongen
International journal of cancer
2000
Corpus ID: 41013689
Coupling of photosensitizers to tumor‐selective monoclonal antibodies ( MAbs ) is an attractive option for improving the…
Expand
1997
1997
Rapid elimination of mouse/human chimeric monoclonal antibodies in nude mice
F. V. van Gog
,
R. Brakenhoff
,
G. Snow
,
G. V. van Dongen
Cancer Immunology, Immunotherapy
1997
Corpus ID: 21818000
Abstract At our laboratory we are currently evaluating the suitability of mouse/human chimeric monoclonal antibodies (cmAb) for…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE